16th St.

 Gallen International Breast

Cancer Conference 2019
Primary Therapy of Women with Early Breast Cancer.  
Evidence, Controversies, Consensus

9 20 – 23 March 2019,  

Austria Center, Vienna / Austria

©WienTourismus / Claudio Alessandri

Programme

For the updated programme, please visit

www.oncoconferences.ch
2 INVITATION AND GENERAL INFORMATION

Invitation Important deadlines

The International Scientific Committee and the 31 August 2018:
­Organising Chairs 2019 invite you again to another Opening poster abstract submission and grant application
(16th) «St. Gallen International Breast Cancer­ on www.oncoconferences.ch/BCC
­Conference» in Vienna / Austria. Experts of virtually 15 December 2018:
all major breast cancer cooperative groups and Closing poster abstract submission and grant application
centers world-wide, actively engaged in basic and 20 December 2018:
clinical ­research as well as in clinical management of Closing early rate registration, regular fee applies
­patients with breast cancer, will again present their 1 March 2019:
latest data, critically reviewed by leading specialists Closing regular registration, late fee applies
in the field. The conference closes as usual with an
update of the widely acknowledged «St. Gallen Registration
­International Consensus on the optimal Primary Register on www.oncoconferences.ch/BCC and visit our
Treatment of Women with Early Breast Cancer». ­website for updated information regarding program,  
faculty and venue.
Organising Chairs 2019
Beat Thürlimann St. Gallen / Switzerland Registration fees
Michael Gnant Vienna / Austria Regular Residents,
Hans-Jörg Senn St. Gallen / Switzerland ­participant nurses
Early bird fee from
750.– Euro 450.– Euro
Scientific Chairs 2019 1 June 2018
Giuseppe Curigliano Milano / Italy Regular fee from
Michael Gnant Vienna / Austria 900.– Euro 650.– Euro
20 December 2018
Martine Piccart-Gebhart Brussels / Belgium Late fee from
Meredith Regan Boston, MA / USA 1050.– Euro 1050.– Euro
1 March 2019
Hans-Jörg Senn St. Gallen / Switzerland
Beat Thürlimann St. Gallen / Switzerland Contact for
Eric P. Winer Boston, MA / USA Industrial exhibition, satellite symposia, registration,
hotel accommodation, networking programme,
Faculty 2019 abstract submission
Around 70 invited top breast cancer specialists from Mondial Congress & Events
major breast cancer study groups and centers Mondial GmbH & Co. KG
world-wide. Operngasse 20b,
AT-1040 Vienna, Austria
Participants phone +43 (0) 1 58804 0, fax +43 (0) 1 58804 185
Around 3000 breast cancer oriented surgeons, bcc19@mondial-congress.com, www.oncoconferences.ch/BCC
gynaecologists, medical- and radio-oncologists,
pathologists, epidemiologists and breast cancer Contact for
nurses from over 100 countries worldwide. Scientific programme, faculty, grants
St. Gallen Oncology Conferences «SG-BCC 2019»
Venue c/o Tumor and Breast Center ZeTuP
Austria Center Vienna (ACV) Rorschacherstrasse 150
Bruno-Kreisky-Platz 1 CH-9006 St. Gallen, Switzerland
AT-1220 Vienna / Austria phone: +41 (0) 71 243 00 32, fax +41 (0) 245 68 05
info@oncoconferences.ch, www.oncoconferences.ch/BCC
 PROGRAMME 3
(subject to changes)

Wednesday, 20 March 2019

08.30 – 14.00 h Satellite Symposia

14.15 – 15.30 h Opening Ceremony; Award Ceremonies:
St. Gallen International Breast Cancer Award lecture by Monica Morrow (USA)
ESO Umberto Veronesi Award Lecture by Dame Lesley Fallowfield (UK)
15.30 – 15.45 h Coffee break
15.45 – 17.15 h Session 1: News since St. Gallen 2017
Chairs: Fatima Cardoso (Portugal), Beat Thürlimann (Switzerland)
17.15 – 17.45 h Coffee break
17.45 – 19.15 h Session 2: Biology of breast cancer I: Risk stratification
Chairs: Suzette Delaloge (France), Peter Dubsky (Austria / Switzerland)
 
Networking opportunity
19.15 – 21.00 h Welcome Apéro (on the premises of the Austria Center Vienna), free for all registered persons

Thursday, 21 March 2019

08.30 – 10.00 h Session 3: Biology of breast cancer II: Prediction of response

Chairs: Giuseppe Curigliano (Italy), C. Kent Osborne (USA)
10.00 – 10.30 h Coffee break, exhibition, posters I
10.30 – 11.45 h Session 4: Risk stratification and prevention in ductal in situ carcinoma
Chairs: Jens Huober (Germany), Jonas Bergh (Sweden)
11.45 – 12.30 h Special lecture I and II
Chair: Michael Gnant (Austria) 
I: Extrapolating data from clinical trials as we are treating patients in real life (Sharon Giordano, USA) 
II: What is the clinical benefit in the treatment of patients with early breast cancer?  
(Ann H. Partridge, USA)
12.30 – 14.00 h Lunch break, exhibition, posters I, Satellite Symposium
14.00 – 15.30 h Session 5: New pathways with potential impact in the treatment of early breast cancer
Chairs: Masazaku Toi (Japan), Jiang Zefei (China)
15.30 – 16.00 h Coffee break, exhibition, posters I
16.00 – 17.30 h Session 6: Treatment tailoring according to pathology and biology
Chairs: Hervé Bonnefoi (France), Meredith Regan (USA)
17.45 – 19.15 h Satellite Symposium
4 PROGRAMME
(subject to changes)

Friday, 22 March 2019

08.30 – 10.00 h Session 7: Surgery of early breast cancer
Chairs: Emiel J.T. Rutgers (The Netherlands), Zhiming Shao (China)
10.00 – 10.30 h Coffee break, posters II, exhibition
10.30 – 12.00 h Session 8: Radiotherapy of early breast cancer 2019
Chairs: Per Karlsson (Sweden), Felix Sedlmayer (Austria)
12.00 – 12.30 h Special lecture III
Chair: Martine Piccart-Gebhart (Belgium) 
Adjuvant and neoadjuvant therapy in patients with early breast cancer: Principles and practical consi-
derations (Eric P. Winer, USA)
12.30 – 14.00 h Lunch break, exhibition, posters II, Satellite Symposium
14.00 – 15.30 h Session 9: Primary and adjuvant systemic therapy of early breast cancer I
Chairs: Daniel F. Hayes (USA), Karen Gelmon (Canada)
15.30 – 16.00 h Coffee break, posters II, exhibition
16.00 – 17.30 h Session 10: Primary and adjuvant systemic therapy of early breast cancer II
Chairs: Olivia Pagani (Switzerland), Sibylle Loibl (Germany)
17.45 – 19.15 h Satellite Symposium

Saturday, 23 March 2019

8.30 – 12.30 h Session 11: St. Gallen International Consensus session on the optimal primary treatment of women
with breast cancer 2019. Seeking consensus on evidence and opinions
Chairs: Giuseppe Curigliano (Italy) and Eric P. Winer (USA) 
Scientific secretaries and consensus co-authors:
Harold J. Burstein (USA) 
Marco Colleoni (Italy) 
Giuseppe Curigliano (Italy) 
Peter Dubsky (Austria / Switzerland) 
Carsten Denkert (Germany) 
Michael Gnant (Austria) 
Sibylle Loibl (Germany) 
Martine Piccart-Gebhart (Belgium) 
Philip Poortmans (The Netherlands/France) 
Meredith Regan (USA) 
Hans-Jörg Senn (Switzerland) 
Beat Thürlimann (Switzerland) 
Eric P. Winer (USA)
12.30 h Farewell